Indefinite Delivery Contract 75D30121D11355
Award Date
6/25/21
Last Date to Order
6/30/22
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention awarded multiple indefinite-delivery, indefinite-quantity contracts to Pfizer Inc. for the delivery of various adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $62.2 million. Through these contracts, Pfizer will provide 12 standard adult vaccines to the CDC including hepatitis A & B, pneumococcal, tetanus/diphtheria, herpes zoster, Tdap, MMR, meningococcal,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
The Centers for Disease Control and Prevention awarded multiple indefinite-delivery, indefinite-quantity contracts valued at up to $25,350,000 to supply adult vaccines for the period of July 1, 2023 through June 30, 2024. The prime contractor is VBI Vaccines (Delaware) Inc. The contracts aim to procure minimum and maximum quantities of 12 adult vaccines, including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles, mumps and rubella,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Merck Sharp & Dohme LLC for adult vaccines. The contracts have a potential value of $83,485,760 and a period of performance from July 1, 2021 to June 30, 2022. Merck will provide 13 standard adult vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, and...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Sanofi Pasteur Inc. for the procurement of adult vaccines. The contracts have a potential value of $39.08 million to supply 13 standard adult vaccines over a one year period from July 1, 2021 through June 30, 2022. Vaccines will be delivered within 15 business days of order to support immunization programs in 50 state health departments and large cities, as provided under Section 317(j) of the Public...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of various adult vaccines. The $118.2 million contract, running from July 1, 2024 to June 30, 2025, covers a diverse array of vaccines including Hepatitis, HPV, Measles/Mumps/Rubella, Meningococcal, Mpox, Pneumococcal, and Varicella. The contract does not utilize any set-asides and allows for...
The Centers for Disease Control and Prevention awarded a multiple-award indefinite delivery contract to Sanofi Pasteur Inc. to procure adult vaccines. With a potential value of $37.2 million, this vehicle provides for the delivery of various vaccine products and services over its one-year ordering period through June 2022. The contract supports the CDC's adult immunization programs by establishing competitive pricing for items like influenza, pneumococcal, tetanus-diphtheria-acellular pertussis,...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an indefinite-delivery, indefinite-quantity (IDIQ) contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a potential value of $87,753,075 and a period of performance from July 1, 2023 through June 30, 2024. The vaccines will be delivered within 15 business days of order receipt and shipped FOB...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Bavarian Nordic, Inc. for the procurement of various adult vaccines. The $99,015,000 multiple-award contract has a period of performance from July 1, 2024 to June 30, 2025. The contract does not utilize any set-asides. The solicitation seeks the purchase of vaccines for Hepatitis A, Hepatitis B, Hepatitis...
Pfizer Inc. is providing adult vaccines to the Centers for Disease Control and Prevention under a multiple award indefinite delivery contract. The contract was awarded on July 1, 2020 with a potential value of $48.8 million. Pfizer will supply vaccines for hepatitis A & B, pneumococcal disease, tetanus, diphtheria, herpes zoster, pertussis, measles, mumps, rubella, meningitis, human papillomavirus, varicella, and serogroup B meningococcal disease. Delivery will support immunization...